NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 11, 2023 at 12:11 am EDT
Share
NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 98.63 million compared to KRW 28.48 million a year ago. Net income was KRW 29,874.45 million compared to KRW 4,848.43 million a year ago. Basic earnings per share from continuing operations was KRW 3,295 compared to KRW 751 a year ago. Diluted earnings per share from continuing operations was KRW 3,295 compared to KRW 349 a year ago. Basic earnings per share was KRW 3,300 compared to KRW 751 a year ago. Diluted earnings per share was KRW 3,300 compared to KRW 349 a year ago.
For the six months, sales was KRW 178.52 million compared to KRW 62.3 million a year ago. Net income was KRW 31,325.2 million compared to KRW 3,295.27 million a year ago. Basic earnings per share from continuing operations was KRW 3,671 compared to KRW 512 a year ago. Diluted earnings per share from continuing operations was KRW 3,671 compared to KRW 269 a year ago. Basic earnings per share was KRW 3,713 compared to KRW 512 a year ago. Diluted earnings per share was KRW 3,713 compared to KRW 269 a year ago.
NexturnBioScience Co Ltd, formerly Nexturn Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of computer numerical control (CNC) automatic lathes. The Company's products are used for automobile parts such as engine parts, steering devices, wipers and others, marine engine parts, medical devices and implants, communication equipment such as mobile phones, digital multimedia broadcasting (DMB) devices and others, electronic components such as liquid crystal display (LCD), copier, printer and others, hydraulic and pneumatic parts, among others. It also provides related parts, after-sales service.
NEXTURNBIOSCIENCE CO., LTD. 
